| Patents for C07C 271 - Derivatives of carbamic acid, i.e. compounds containing any of the groups the nitrogen atom not being part of nitro or nitroso groups (15,621) |
|---|
| 05/24/2005 | CA2174000C Process for the preparation of a substituted 2,5-diamino-3-hydroxyhexane |
| 05/19/2005 | WO2005044795A1 Process for the preparation of ccr-2 antagonist |
| 05/19/2005 | US20050107543 Fluoro linkers and their use as linkers for enzyme-activated drug conjugates |
| 05/19/2005 | US20050107334 Acyloxyalkyl carbamate prodrugs, methods of synthesis and use |
| 05/18/2005 | EP1429996B1 Method for obtaining an ammonium carbamate solution from a gas mixture containing ammonia, water and carbon dioxide |
| 05/18/2005 | CN1617881A Chemical process |
| 05/18/2005 | CN1617854A Pheny(alkyl)carboxylic acid derivatives and dionic phenylalkylheterocyclic derivatives and their use as medicines with serum glucose and/or serum lipid lowering activity |
| 05/18/2005 | CN1616453A Antivirally active heterocyclic azahexane derivatives |
| 05/18/2005 | CN1616419A Separating and purifying method for fenoxycarb |
| 05/18/2005 | CN1202093C Substituted heterocyclic compound |
| 05/17/2005 | US6894185 Substituted chiral allosteric hemoglobin modifiers |
| 05/17/2005 | US6894111 Organic electrochromic materials and polymers for optical attenuation in the near infrared region |
| 05/17/2005 | CA2103845C 9-[(substituted glycyl)-amido]-6-demethyl-6-deoxytetracyclines |
| 05/12/2005 | WO2005042481A2 COMPOUNDS AND RELATED METHODS FOR MUTANT p53 REACTIVATION |
| 05/12/2005 | WO2005042475A2 Carbamoyl esters that inhibit cholinesterase and release pharmacologically active agents |
| 05/12/2005 | WO2005042474A1 Diamine derivative, process for producing the same, and plant disease control agent containing the same as active ingredient |
| 05/12/2005 | WO2005042472A2 Hydroxypropyl amides for the treatment of alzheimer’s disease |
| 05/12/2005 | WO2005000803A8 Asymmetric urea compound and process for producing asymmetric compound by asymmetric conjugate addition reaction with the same as catalyst |
| 05/12/2005 | WO2004092145A8 Alpha substituted carboxylic acid as ppar modulators |
| 05/12/2005 | US20050101781 Eponemycin and epoxomicin analogs and uses thereof |
| 05/12/2005 | US20050101671 Compounds and compositions for delivering active agents |
| 05/12/2005 | US20050101610 Antiischemic agents; brain disorders; cardiovascular disorders; for the alleviation or treatment of symptoms due to neurodegenerative diseases and symptoms derived from diabetes, arteriosclerosis and inflammatory diseases ; for example, N-tert-butoxycarbonyl-4-[4-(4-fluorophenoxy)phenyl]-4-piperidinol |
| 05/12/2005 | CA2543756A1 Hydroxypropyl amides for the treatment of alzheimer's disease |
| 05/12/2005 | CA2543322A1 Carbamoyl esters that inhibit cholinesterase and release pharmacologically active agents |
| 05/11/2005 | EP1529030A2 Derivatives of glycinergic r(+)-2-amino-3-hydroxypropanoic acid |
| 05/11/2005 | CN1615295A Compounds for treatment of inflammation, diabetes and related disorders |
| 05/11/2005 | CN1615284A Method for forming a carbon-carbon or carbon-heteroatom linkage |
| 05/11/2005 | CN1200713C New (aminopropyl) methylphosphinic acids |
| 05/10/2005 | US6890994 Curable coating compositions with carbamate-containing acrylic polymers |
| 05/10/2005 | US6890932 Anthranilic acid derivative |
| 05/10/2005 | CA2097044C Cyclopentane- and -pentene-.beta.-amino acids |
| 05/06/2005 | WO2005040102A2 Novel compounds and their use as antidiabetic and hypolipidemic agents, process for their preparation and pharmaceutical compositions containing them |
| 05/06/2005 | WO2004089880A3 Carbamates useful as fragances |
| 05/06/2005 | WO2004002939A3 Aminoalcohol derivatives |
| 05/05/2005 | US20050096478 Derivatives of fluoro(hydro)carbons attached to an -alkylene-oxy-carbonyl-leaving group; reactive with amine-containing compounds to form a fluoro-substituted carbamyl protective group useful for the efficient separation, recovery and purification of synthsized organic compounds; libraries |
| 05/05/2005 | US20050096477 Astaxanthin esters |
| 05/05/2005 | US20050096387 Carbamoyl esters that inhibit cholinesterase and release pharmacologically active agents |
| 05/05/2005 | US20050096361 and their carbamate-protected derivatives; Stereoselective synthesis from a 1-phenyl-2-(silyl)pentan-3-one and a toluensulfonylmethylcarbamate, cleavage of the oxycarbonyl; analgesic, anxiolytic , antidepressant; 5-(4-tert-butyl-phenyl)-1-isopropyl-2-methyl-3-oxo-pentyl]-carbamic acid benzyl ester |
| 05/05/2005 | US20050096357 Antibiotics; therapy for infections which is caused by drug-resistant Streptococcus, or bacteria infections |
| 05/05/2005 | US20050095280 Cationic lipids as delivery vectors for nucleic acids, peptides and other synthetic drugs, in vitro and in vivo; form stable lamellar structures (liposomes) at physiological pH but destabilize to micelles at acidic and alkaline pH |
| 05/04/2005 | EP1259477B1 Aminoadamantane derivatives as therapeutic agents |
| 05/04/2005 | EP0958280B1 Arylpiperidinopropanol and arylpiperazinopropanol derivatives and pharmaceuticals containing the same |
| 05/04/2005 | CN1612887A Phosphino-aminophosphines |
| 05/04/2005 | CN1612871A Processes and intermediates for preparing benzyl epoxides |
| 05/04/2005 | CN1611489A Intermediates for the synthesis of benzimidazole compounds and process for preparation thereof |
| 05/03/2005 | US6888012 Reducing an alpha -haloketone compound by asymmetric hydrogen transfer in presence of a group 9 transition metal compound having a substituted or unsubstituted cyclopentadienyl group and an optically active diamine compound |
| 05/03/2005 | CA2190570C Process for producing 3-amino-2-oxo-1-halogenopropane derivatives |
| 04/28/2005 | WO2005037784A2 Crystalline form of gamma-aminobutyric acid analog |
| 04/28/2005 | WO2005037779A2 Novel dipeptidyl peptidase iv inhibitors used for functionally influencing different cells and treating immunological, inflammatory, neuronal, and other diseases |
| 04/28/2005 | WO2005037206A2 Anti-cancer compounds and methods of use thereof |
| 04/28/2005 | WO2005037205A2 Haloacetamide and azide substituted compounds and methods of use thereof |
| 04/28/2005 | WO2005019163A3 Acyloxyalkyl carbamate prodrugs, methods of synthesis and use |
| 04/28/2005 | WO2005007091A3 Histone deacetylase inhibitors and methods of use thereof |
| 04/28/2005 | WO2004014844A3 Aryl and heteroaryl compounds and methods to modulate coagulation |
| 04/28/2005 | US20050090669 Aminoalcohol derivatives as beta-3 adrenergic receptor agonists |
| 04/28/2005 | US20050090546 Compounds such as N,N-dibenzylphenylalanine benzyl ester, used as enzyme inhibitors; prophylaxis of lymphadenopathy associated virus, cancer and malaria |
| 04/28/2005 | US20050090539 Intermediates for making 1(alpha-amino-1-(cyclopropyl-fused pyrrolidinylcarbonyl)methyl)-3-hydroxyadamantanes, e.g., methyl 3-hydroxy-<a-oxotricyclo[3.3.1.13,7]decane-1-acetate |
| 04/28/2005 | CA2542807A1 Novel dipeptidyl peptidase iv inhibitors used for functionally influencing different cells and treating immunological, inflammatory, neuronal, and other diseases |
| 04/27/2005 | EP1144360B1 A method for the synthesis of compounds of formula 1 and derivatives thereof |
| 04/27/2005 | EP0968197B1 Efficient synthesis of a 1,4-dihydro-2h-3,1-benzoxazin-2-one |
| 04/27/2005 | CN1198800C 2-(2-chlorophenyl)-3,4-dihydro-2H-pyrrol derivs. |
| 04/26/2005 | US6884905 Reacting a hydroxylamine hydrochloride with an acrylate to form acrylic hydroxyamine, reacting the intermediate with a diisocyanate to form the crosslinker |
| 04/26/2005 | CA2131182C Method for making intermediates useful in synthesis of retroviral protease inhibitors |
| 04/21/2005 | WO2005020882A3 Compound capable of binding s1p receptor and pharmaceutical use thereof |
| 04/21/2005 | WO2005016866A3 Process for producing optically actiive beta-amino acid derivatives |
| 04/21/2005 | CA2542012A1 A method for producing aminopyrrolidine derivatives and intermediate compounds |
| 04/20/2005 | EP1524262A1 Inhibitors of histone deacetylase |
| 04/20/2005 | EP1165495B1 Resorcinol derivatives |
| 04/20/2005 | EP1144395B1 2-amino-benzoxazinone derivatives for the treatment of obesity |
| 04/20/2005 | EP1143977B1 2-oxy-benzoxazinone derivatives for the treatment of obesity |
| 04/20/2005 | CN1607201A Method for the stereoselective synthesis of cyclic amino acids |
| 04/20/2005 | CN1607200A Intermediates for preparation of arthropodicidal oxadiazines |
| 04/20/2005 | CN1197843C Fluorodiol and application thereof |
| 04/14/2005 | WO2005033180A1 Aspartate derivatives and process for their preparation |
| 04/14/2005 | WO2005033066A2 Arylalkylcarbamate derivatives, preparation method thereof and use of same in therapeutics |
| 04/14/2005 | WO2005033064A1 Process of preparing o-carbamoyl compounds in the presence of active amine group |
| 04/14/2005 | WO2005009928A3 Preparation and use of alkylating agents |
| 04/14/2005 | US20050080268 Process of preparing O-carbamoyl compounds in the presence of active amine group |
| 04/14/2005 | US20050079587 Beginning with diastereo-and enantioselective reduction of a keto ester to obtain the hydroxy ester; use in drug preparation |
| 04/14/2005 | CA2541303A1 Process of preparing o-carbamoyl compounds in the presence of active amine group |
| 04/14/2005 | CA2540660A1 Aspartate derivatives and process for their preparation |
| 04/14/2005 | CA2539849A1 Arylalkylcarbamate derivatives, preparation method thereof and use of same in therapeutics |
| 04/13/2005 | EP1521733A1 Modulators of the glucocorticoid receptor |
| 04/13/2005 | EP1077938B1 2-(2-methylphenyl)-3,4-dihydro-2h-pyrrol derivatives |
| 04/12/2005 | US6878841 Diethyloctandioldicarbamates and diethyloctandioldiallophanates, method for the production and use thereof |
| 04/12/2005 | US6878732 5,7-diazaspiro(3.4)octane and -octene derivatives; treating diseases including emesis, depression, anxiety and cough |
| 04/12/2005 | US6878492 Solid polymer electrolyte |
| 04/07/2005 | WO2005030135A2 Nitrosated glutamic acid compounds, compositions and methods of use |
| 04/07/2005 | WO2005014533A3 Aryl and heteroaryl compounds, compositions, and methods of use |
| 04/07/2005 | US20050075512 Diamine derivatives, process for producing the same, and bactericide containing the same as active ingredient |
| 04/07/2005 | US20050075476 Process for preparing aspartates |
| 04/07/2005 | US20050075453 Method for producing aqueous polymer dispersions containing colorants |
| 04/07/2005 | US20050075394 Phenethanolamine derivatives for treatment of respiratory diseases |
| 04/07/2005 | US20050075378 Modulators of peroxisome proliferator activated receptors (ppar) |
| 04/07/2005 | US20050075377 Compounds for elevating plasma lipid levels with prodrugs for humans and other mammals |
| 04/07/2005 | CA2539973A1 Nitrosated glutamic acid compounds, compositions and methods of use |
| 04/06/2005 | EP1519915A2 Tricyclic steroid hormone nuclear receptor modulators |
| 04/06/2005 | EP1227809B1 Heteroatom-interrupted analogs of 15-hydroxyeicosatetraenoic acid and methods of use |
| 04/06/2005 | EP0966435B1 Aminoindan derivatives |
| 04/06/2005 | CN1604890A 取代的环己烷衍生物 Substituted cyclohexane derivatives |